FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...